SLC30A8 rs13266399: Type 2 Diabetes Risk and Zinc Transport
The rs13266399 variant (commonly evaluated alongside rs13266634) is a missense polymorphism located in the SLC30A8 gene, leading to an Arg325Trp amino acid substitution. This gene encodes zinc transporter 8 (ZnT8), a specialized protein that shuttles zinc ions into pancreatic beta cells to facilitate insulin crystallization and storage. Genome-wide association studies link this genetic change to modest statistical variations in insulin secretion and lifetime susceptibility to type 2 diabetes.
What each genotype means
| Genotype | What the research suggests | Reading |
|---|---|---|
| CC | Homozygous for the common major allele (encoding Arg325). This genotype is statistically associated with a modest relative increase in type 2 diabetes risk and slightly reduced first-phase insulin secretion compared to protective alleles. | Higher attention |
| CT | Heterozygous carrier of one risk allele and one protective allele (Arg325/Trp325). This genotype exhibits an intermediate statistical risk profile and average insulin secretory responses relative to general population baselines. | Informational |
| TT | Homozygous for the minor allele (encoding Trp325). This genotype is associated with a modest relative protective effect against type 2 diabetes, higher insulin responsiveness during glucose challenges, and slightly lower average fasting glucose. | Favorable |
Genomic Location and the Arg325Trp Polymorphism
The rs13266399 single nucleotide polymorphism sits on chromosome 8 within the solute carrier family 30 member 8 gene, denoted as SLC30A8. This genetic marker represents an exonic missense variation closely linked in high linkage disequilibrium with rs13266634. The substitution alternates between coding for an arginine residue and a tryptophan residue at amino acid position 325 (Arg325Trp) within the carboxy-terminus of the resulting protein. Because it alters the primary amino acid sequence of an active transporter, this polymorphism has served as a central focal point for functional molecular biology and metabolic research. Despite changing the structural peptide sequence, it is considered a common non-synonymous variant found across diverse global populations rather than a rare, disruptive disease mutation.
Biological Role of the SLC30A8 Zinc Transporter
SLC30A8 encodes zinc transporter 8 (ZnT8), a transmembrane transport protein expressed almost exclusively within pancreatic islet cells, particularly insulin-producing beta cells and glucagon-secreting alpha cells. In beta cells, ZnT8 is embedded in the membranes of insulin secretory granules, where it actively transports zinc ions from the cytoplasm into the granule lumen. High concentrations of luminal zinc are necessary for insulin hexamer crystallization, packaging, and safe storage prior to secretion into the bloodstream. Variations in ZnT8 function influence cellular zinc transport kinetics, granular proinsulin conversion, and the magnitude of first-phase glucose-stimulated insulin release. The transporter thereby directly influences the pancreatic endocrine machinery that maintains normal systemic glucose balance.
Epidemiological Research and Association Strength
Large-scale genome-wide association studies (GWAS) and meta-analyses, cataloged across cohorts in Europe, East Asia, and the Americas, consistently observe modest statistical shifts in metabolic traits associated with the Arg325Trp locus. The major arginine-encoding allele (Arg325) correlates with approximately a 10% to 20% relative increase in type 2 diabetes risk per copy (odds ratios typically ranging between 1.12 and 1.19), alongside modest reductions in acute insulin release. Conversely, carrying the minor tryptophan-encoding allele (Trp325) is associated with slight relative protection and lower fasting glucose levels. Although the statistical evidence is strong and highly reproducible across large population cohorts, the clinical effect size of this individual common variant remains modest on an individual level.
Population Frequency and Ancestral Distribution
Alleles at the SLC30A8 Arg325Trp locus vary in prevalence among continental ancestral populations. The risk-associated arginine allele is the major allele worldwide, occurring at frequencies between 70% and 80% in populations of European ancestry. In East Asian populations, the minor protective tryptophan allele appears at somewhat higher frequencies than in European cohorts, although the directional association with metabolic biomarkers and diabetes susceptibility remains broadly consistent. Because the risk allele is ubiquitous and forms the baseline genotype for hundreds of millions of healthy individuals globally, carrying this variant is not an anomaly, nor does it independently drive disease outside of broader polygenic and lifestyle contexts.
Translating Genetic Results into Context
Direct-to-consumer genetic testing often highlights rs13266399 due to its clear biological mechanism, but this single variant cannot diagnose or definitively predict type 2 diabetes. Type 2 diabetes is a complex polygenic condition influenced by hundreds of genetic loci alongside major lifestyle factors such as dietary patterns, physical activity, sleep, adiposity, and age. Possessing the statistical risk genotype does not guarantee diabetes, nor does the protective genotype confer immunity. Genotypic findings should be treated purely as educational data. Anyone seeking to assess or manage their metabolic health or glucose levels should consult qualified healthcare professionals for standard clinical screening, such as fasting plasma glucose or HbA1c testing.
How common is this variant?
The risk-increasing allele is common worldwide, present in approximately 70% to 80% of individuals of European descent, while the minor protective allele occurs at slightly higher frequencies in East Asian populations.
Frequently asked questions
Does carrying the rs13266399 risk allele mean I will develop type 2 diabetes?
No. The variant confers only a very modest statistical increase in relative risk (roughly 10% to 20% per allele). The vast majority of people with this allele never develop diabetes, as metabolic health is predominantly shaped by overall polygenic background, nutrition, exercise, and body composition.
What is the biological function of the SLC30A8 gene?
SLC30A8 produces zinc transporter 8 (ZnT8), a specialized channel protein located on the membranes of insulin secretory granules in pancreatic beta cells. It pumps zinc into these storage compartments, which helps stabilize and crystallize insulin until it is secreted.
Should I take zinc supplements if I carry the risk genotype?
Current scientific guidelines do not recommend altering dietary zinc supplementation based purely on your SLC30A8 genotype. The variant affects intracellular zinc transport within specialized pancreatic beta cells rather than overall systemic zinc deficiency. Always consult a healthcare provider or registered dietitian before starting new dietary supplements.
Can rs13266399 guide my diabetes medication dosing?
No, this variant is not used to guide therapeutic regimens or medication dosing in clinical practice. Any treatment choices, glucose monitoring plans, or pharmacotherapy must be determined in collaboration with a licensed medical professional.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs13266399?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29